a month ago
KYMR
AnalystsSudan LoganathanSudan Loganathan's Stock Forecasts
AnalystsSudan Loganathan
Sectors:
Industries:
Analyst Ranking
Top 46%
#2411 out of 5230 analysts
Average Return
+0.06%
Win Rate
47%21 out of 45
Risk vs Reward
Poor
Good
Sudan Loganathan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adc Therapeutics SaADCT | +175.63% | $1.60 | $4.41 | 2025-02-24 - 2026-02-23 | Strong Buy |
Immunome IncIMNM | +140.53% | $8.66 | $20.83 | 2025-03-20 - 2026-03-19 | Strong Buy |
Delcath Systems IncDCTH | +116.27% | $7.07 | $15.29 | 2024-05-14 - 2025-05-13 | Strong Buy |
Kymera Therapeutics IncKYMR | +55.93% | $43.70 | $68.14 | 2025-01-21 - 2026-01-20 | Strong Buy |
Kymera Therapeutics IncKYMR | +51.14% | $42.41 | $64.10 | 2024-11-18 - 2025-11-17 | Strong Buy |
Sudan Loganathan Analyst Color
Get additional color on Sudan Loganathan's coverage of popular stocks
4 months ago
KYMR
4 months ago
PYXS
Sudan Loganathan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunome IncIMNM | 4 | Strong Buy | $30.00 | +52.98% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $100.00 | +27.94% | Maintains | a month ago |
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $95.00 | +22.08% | Initiates Coverage On | 3 months ago |
Candel Therapeutics IncCADL | 2 | Strong Buy | $15.00 | +211.85% | Reiterates | 4 months ago |
Pyxis Oncology IncPYXS | 2 | Strong Buy | $8.00 | +510.69% | Maintains | 4 months ago |
Arvinas IncARVN | 3 | Strong Buy | $15.00 | +48.51% | Maintains | 5 months ago |
Delcath Systems IncDCTH | 4 | Strong Buy | $18.00 | +100.67% | Maintains | 5 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $35.00 | +21.95% | Initiates Coverage On | 5 months ago |
C4 Therapeutics IncCCCC | 3 | Strong Buy | $6.00 | +148.96% | Reiterates | 6 months ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $45.00 | +47.73% | Reiterates | 7 months ago |
Nurix Therapeutics IncNRIX | 4 | Strong Buy | $30.00 | +103.25% | Reiterates | 9 months ago |
Exelixis IncEXEL | 5 | Strong Buy | $60.00 | +44.47% | Upgrades | 9 months ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $135.00 | +4.28% | Downgrades | 10 months ago |
Elevation Oncology IncELEV | 3 | Strong Buy | $5.00 | N/A | Reiterates | a year ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $33.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 2 | Hold | $15.00 | N/A | Reiterates | a year ago |
Actinium Pharmaceuticals IncATNM | 2 | Strong Buy | $5.00 | N/A | Reiterates | a year ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $100.00 | N/A | Reiterates | 2 years ago |
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.